/Sky Labs signs deal with Germany's IEM to bring ring BPM to Europe
NEWS

6d ago

Sky Labs signs deal with Germany's IEM to bring ring BPM to Europe

Korea Biomedical Review
2026/08/31

Sky Labs said Monday it has signed a supply agreement with German ambulatory blood pressure monitoring (ABPM) company IEM GmbH to sell its ring-shaped BPM to hospitals and clinics in the U.K. and Europe.

The Korean company said it recorded 2.6 billion won ($1.9 million) in initial sales from the deal in the first half of 2026.

IEM GmbH CEO Thomas Korth (left) and Sky Labs CEO Lee Byung-hwan pose for a photo after signing the European supply agreement for the clinic-use CART BP (blood pressure) monitor. (Courtesy of Sky Labs)

The device, marketed as the clinic-use CART BP monitor, is worn on the finger and measures BP over 24 hours, a task usually performed by cuff-type (CB) monitors that inflate around the upper arm. Sky Labs said the ring form avoids the sleep and activity disruption caused by CB devices, making it easier to detect nighttime hypertension.

Under the agreement, Sky Labs will integrate the monitor with IEM's ABPM software, called FLOW, so that clinics can use it in routine practice. IEM distributes BPMs to hospitals across the U.K. and Europe.

The companies will begin preparing for adoption by medical institutions starting in the U.K. before expanding elsewhere in Europe, Sky Labs said.

Sky Labs said the device is reimbursed under Korea's public health insurance and is listed in the Korean Society of Hypertension's treatment guidelines, and that it carries European medical device certification under the Conformité Européenne (European Conformity) Medical Device Regulation (CE MDR). The company described it as the first cuffless BPM to obtain domestic reimbursement and a guideline listing.

Summary

Sky Labs said Monday it has signed a supply agreement with German ambulatory blood pressure monitoring (ABPM) company IEM GmbH to sell its ring-shaped BPM to hospitals and clinics in the U.K. and Europe.The Korean company said it recorded 2.6 billion won ($1.9 million) in initial sales from the deal